Institutional investors purchased a net $9.3 million shares of TEVA during the quarter ended June 2015, and now own 54.66% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH (... Bought 821.7 Thousand shares of Teva Pharmaceutical